BioCentury | Apr 9, 2021
Product Development

Ventus raises RA-led $100M series B that will enable human trials, open path to IPO

...platform —ReSOLVE —to its tool kit...
BioCentury | Apr 6, 2021
Management Tracks

Memories of John Martin, plus AACR’s hot targets and a Bio€quity Europe preview: a BioCentury podcast

...partnered for a second time with Gilead. The deal underscores how fruitful AbCellera’s growing tool kit...
BioCentury | Apr 1, 2021

Gilead again partners with AbCellera, forging multitarget deal that draws on biotech’s growing tool kit

Gilead’s multitarget antibody discovery deal with AbCellera will draw on a growing toolbox, including a humanized mouse model and a bispecifics platform, that the biotech has built over the course of a year in which...
BioCentury | Mar 31, 2021

March 31 Quick Takes: Basket of EU approvals includes MS, SMA drugs; plus Amarin, AbbVie, Cara-Vifor

...gastrointestinal stromal tumors in a fourth-line setting. The cross-border in-licensing company holds rights to the PDGFRA/c-KIT...
BioCentury | Mar 30, 2021

With ADC pipeline now a top priority, Pyxis adds $152M series B

...its three ADC candidates and add flexibility to create new conjugated therapeutics based on a tool-kit...
BioCentury | Mar 29, 2021
Product Development

March 29 Quick Takes: Humanigen mAb meets COVID endpoint; plus Merck, Wave, Celldex, Ionis, Orphazyme and uniQure

...that specifically binds the receptor tyrosine kinase KIT...
BioCentury | Mar 18, 2021

Led by ex-Springworks exec, Pyxis forges deal to gain access to Pfizer’s ADCs, platform tech

...companies’ specific working relationship, but told BioCentury the biotech will have access to a scientific tool-kit...
BioCentury | Mar 17, 2021
Product Development

FDA gets explicit about asymptomatic screening tests

...serial manner outside of a testing program.” The March 5 authorization of a home test kit...
BioCentury | Mar 6, 2021
Product Development

Cue’s OTC home molecular test opens the door to routine self-screening

...material, is more sensitive than previously authorized at-home tests, including those detecting viral proteins.Cue’s test kit...
BioCentury | Mar 2, 2021
Product Development

Suspension of partnered Genentech program slows Adaptive’s first push into therapeutics

...also developing a platform to identify neutralizing antibodies for therapeutic use, and markets a research tool-kit...
Items per page:
1 - 10 of 2398